Physician profile
Joseph Motta
NPI 1871575878
$2,014.96
in general payments reported to CMS, 2019-2025
22 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $343 · 2021: $674 · 2024: $98.39 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $383.61 | 2021 | |
| Astellas Pharma US INC | $368.68 | 2019-2021 | |
| Silk Road Medical, INC. | $198.46 | 2020 | |
| Chiesi USA, INC. | $122.34 | 2019 | |
| La Jolla Pharmaceutical Company | $120.65 | 2019 | |
| Mayne Pharma Commercial LLC | $113.98 | 2024-2025 | |
| Teleflex LLC | $79.06 | 2021 | |
| Verity Pharmaceuticals INC. | $72.54 | 2025 | Tlando |
| Azurity Pharmaceuticals, INC. | $69.57 | 2024-2025 | Azmiro |
| Evofem Biosciences, INC. | $69.13 | 2024-2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $61.04 | 2025 | Femlyv |
| Dentsply Ih Ab | $54.58 | 2025 | Lofric |
| Tolmar, INC. | $50.98 | 2024-2025 | Jatenzo |
| Boston Scientific Corporation | $50.15 | 2019-2025 | Varithena Administration Pack |
| Ambu INC. | $31.99 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $30.46 | 2021 | |
| Janssen Biotech, INC. | $26.10 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.32 | 2025 | |
| Acerus Pharmaceuticals Corporation | $24.15 | 2020 | |
| Endo USA, INC. | $23.89 | 2025 | Xiaflex |
| Antares Pharma, INC. | $21.03 | 2025 | Xyosted |
| Endo Pharmaceuticals INC. | $17.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Motta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.